Sanopao, Analyn B.

HRN: 12-32-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
METRONIDAZOLE 500MG (TAB)
09/11/2024
09/18/2024
ORAL
500mg
TID
Amoebiasis; Trichomoniasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: